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Compared to native peptides peptidomimetics
offers many advantages as newly designed drugs. The
benefits include enhanced stability to proteolytic
enzymes, better transport through cellular membranes,
increased bio-availability, changing agonist to antago-
nists potency and higher affinity in ligand-receptors
interactions. D-amino acids are used to design and
obtain new peptidomimetics by their incorporation in
place of the natural L-amino acids, either at a specific
position, or throughout the whole peptide. D-phenylala-
nine is one of the preferred amino acids. Addition of
hydrophobic phenyl ring results in better transport prop-
erties of peptidomimetics through cellular membranes
and better enzymatic stability (1, 2).
Up to now D-phenylanine and derivatives have
been successfully used in design of new efficient pep-
tidomimetics. 4-fluoro-D-phenylalanine derivative
implicate in new agonist of melanocortin receptors
(MCRs). A common structural feature present in all
endogenous ligands (MSH, ACTH) of the melanocortin
receptors (MCRs) is His-Phe-Arg-Trp sequence, which
has been identified as the minimal peptide fragment
necessary for activating the receptors. Further structural
modifications toward α-MSH showed that inverting Phe
to the D-configuration resulted in an analog with
enhanced potency and enzymatic stability. Replacement
of the phenyl ring of D-Phe side chain in one of His-D-
Phe-Arg-Trp analogue with 4-fluorophenyl group led to
potent MCRs agonist with enhanced selectivity (3).
Synthetic decapeptides, Cetrorelix and Abarelix
belong to third-generation of modified gonadotropin
releasing hormone (GnRH) antagonists and contain in
their structures D-4-chlorophenylalanine. GnRH, a linear
decapeptide synthesized by gonadotropic cells of hypo-
thalamus, is a central mediator of the human reproductive
axis. Cetrorelix and Abarelix reveal high antagonistic
activity against naturally occurring GnRH and are used
for treatment of sex hormone-dependent disorders (4, 5).
Another important example of peptidomimetic
with D-phenylalanine presence is Octreotide ñ a syn-
thetic somatostatin analogue with similar but more pro-
longed pharmacological effects. Octreotide is used to
treat acromegaly and also to reduce flushing episodes
and watery diarrhoea caused by cancerous tumors (car-
cinoid syndrome) (6).
Furthermore, D-amino acidñcontaining peptides
are especially important as pharmaceuticals due to their
strong antibacterial activity. Many of them (Bacitracin
A, Fungisporin, Gramicidin S, Tyrocidine, Polymyxin,)
contain D-phenylalanine (2).
In the present work we report the application of hydan-
toinase method to obtain D-phenylalanine derivatives.
Hydantoinase method consist of three steps: 
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Figure 1. Figure 2.
1. chemical and/or enzymatic racemization of
D,L-5-substituted hydantoin
2. opening of the hydantoin ring to the N-car-
bamoyl-D-amino acid by D-hydantoinase (E.C.3.5.2.2)
(6).
3. converting of the N-carbamoyl-D-amino acid to
the D-amino acid by diazotization or by the next enzy-
matic reaction catalyzed by N-carbamylase (E.C.3.5.1)
(7).
In our research phenyl ring substituted 5-benzyl-
hydantoins were obtained in racemic form from cheap
starting materials such as benzylaldehyde derivatives
and hydantoin using first Knoevenagel condensation
and next the reduction of unsaturated bond in 5-position
of the hydantoin (Figure 1). Obtained ring substituted 5-
benzylhydantoin derivatives were used as substrates for
immobilized, recombinant from Escherichia coli D-
hydantoinase. The enzyme catalyzed the enantioselec-
tive hydrolytic ring-opening of racemic hydantoin to
form N-carbamoyl-D-amino acid, which was next con-
verted by diazotization to the corresponding enan-
tiomerically pure D-amino acid (Figure 2).
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Table 1. 5-Arylidenehydantoin (1-10) and 5-benzylhydantoin (1a-10a) derivatives.
Yield m. p. Molecular mass
Comp. R [%] [OC] formula Rf A 
1 2-F 65 222-224 206,17 0,46
C10H7FN2O2 
1a 2-F 90 191-192 208,19 0,28
C10H9FN2O2
2 3-F 90 210-212 206,17 0,51
C10H7FN2O2
2a 3-F 92 192 208,19 0,21
C10H9FN2O2
3 4-F 86 243-250 206,17 0,49
C10H7FN2O2
3a 4-F 94 200-201 208,19 0,19
C10H9FN2O2
4 2-Br 33,8 300-302 267,08 0,46
C10H7BrN2O2
4a 2-Br 80 252-253 269,09 0,30
C10H9BrN2O2
5 3-Br 65 235-237 267,08 0,60
C10H7BrN2O2
5a 3-Br 91 193-194 269,09 0,29
C10H9BrN2O2
6 4-Br 77 307-309 267,08 0,55
C10H7BrN2O2
6a 4-Br 88,5 199-200 269,09 0,23
C10H9BrN2O2
7 2-CH3 69,3 199-201 202,21 0,69
C11H10N2O2
7a 2-CH3 63,7 175-177 204,23 0,37
C11H10N2O2
8 3-CH3 44,5 226-228 202,21 0,70
C11H10N2O2
8a 3-CH3 49,5 184-186 204,23 0,38
C11H10N2O2
9 4-CH3 61,9 263-266 202,21 0,69
C11H10N2O2
9a 4-CH3 58,8 208-210 204,23 0,38
C11H10N2O2
10 2,4-CH3 60,2 183-185 216,24 0,68
C12H12N2O2
10a 2,4-CH3 18,4 215-217 218,25 0,41
C12H14N2O2
A = chloroform/ethyl acetate (1:1, v/v)
EXPERIMENTAL
Chemicals and reagents
Hydantoin, benzylaldehyde derivatives, red phos-
phorus, sodium acetate, ammonium acetate and solvents
which were used in chemical synthesis of 5-benzylhy-
dantoin derivatives were obtained from commercial
suppliers and used without further purification.
Biotransfomations were carried out in borate buffer pH
= 9 (Merck) with commercially available D-hydan-
toinase (E.C 3.5.2.2), immobilized, cloned and
expressed in Escherichia coli, (Fluka, 53,1 U/g activity).
General methods
All melting points were measured in glass capil-
lary tubes using Mel-TempÆ Laboratory Devices Inc.
USA apparatus and are uncorrected. 1H-NMR spectra
were recorded on Varian Mercury-VX instrument at 300
MHz using TMS as an internal standard in DMSO-d6.
IR spectra were recorded in KBr pellets using a Jasco
FT/IR-410 spectrophotometer. Reactions under
microwave irradiation were performed using Samsung
M1618 domestic microwave oven.
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Table 2. IR and 1H NMR spectral data of compounds 1a-10a.
I R
No. (KBr)[cm-1] 1H NMR δ (ppm)
NH C=O (2) C=O (4)
1a 3184 1733 1781 2,85-2,90 (dd, J=6,4 Hz,1H, H -C-H); 3,00-3,05 (dd, J=4,9 Hz, 1H, H-C-H);
4,29 (t, J=5,6 Hz, 1H, CH); 7,12 (q, J=7,6Hz, 2H, Ph-3-H, Ph-6-H ); 7,26 
(t, J=6,9 Hz, 2H, Ph-4-H, Ph-5-H); 7,92 (s, 1H, N1H); 10,52 (s, 1H, N3H);
2a 3179 1734 1780 2,93 (qu, J=7,1 Hz, 2H, CH2); 4,34 (t, J=5,2 Hz, 1H, CH); 6,99-7,07 (m, 3H, 
Ph-2-H, Ph-4-H, Ph-6-H); 7,31(q, J=7,4 Hz, 1H, Ph-5-H); 7,91(s, 1H, N1H); 
10,47 (s, 1H, N3H);
3a 3245 1708 1757 2,96 (d, J=4,9 Hz, 2H, CH2); 4,30 (t, J=4,9 Hz, 1H, CH); 7,06-7,21 (m, 4H,
Ph-2-H, Ph-3-H, Ph-5-H, Ph-6-H); 7,89 (s, 1H, N1H); 10,42 (s, 1H, N3H);
4a 3187 1731 1783 2,88-2,96 (dd, J=9,0 Hz, 1H, H -C-H); 3,16-3,22 (dd, J=5,0 Hz, 1H, H-C-H); 
4,32 (t, J=5,0 Hz, 1H, CH); 7,17 ñ 7,24 (m, 1H, Ph-6-H); 7, 30 ñ 7, 35 (m, 2H,
Ph-4-H, Ph-5-H); 7, 59 (d, J=7,0Hz, 1H, Ph-3-H); 7,91 (s, 1H, N1H); 10,67 (s,
1H, N3H);
5a 3239 1700 1756 2.94 (t, J= 5,-Hz, 2H, CH2); 4,36 (t, J=5,0 Hz, 1H, CH); 7,13-7,18 (m, 1H, Ph-2-H);
7,26-7,35 (m, 4H, Ph-4-H, Ph-5-H, Ph-6-H), 7,93 (s, 1H, N1H); 10,72 (s, 1H,
N3H);
6a 3241 1706 1756 2,89(q, J=10,0 Hz, 2H, CH2); 3,34 (t, J=10,0 Hz, 1H, CH); 7,35 (d, J=8,0 Hz 
2H, Ph-2-H, Ph-6-H); 7,48 (d, J=8,0 Hz, 2H, Ph-3-H, Ph-5-H); 7,94 (s, 1H, 
N1H); 10,48 (s, 1H, N3H);
7a 3185 1730 1784 2,26 (s, 3H,CH3);2,80-2,87 (dd, J=14,4 Hz, 1H, H -C-H); 2,96-3.02 (dd, J=14,4 
Hz, 1H, H -C-H); 4,28 (m, 1H, CH); 7,06 (m, 4H, Ph-2-H, Ph-3-H,Ph-4-H, Ph-
5-H); 7,89(s, 1H, N1H); 10, 52(s, 1H, N3H);
8a 3225 1728 1782 2,24(s, 3H, CH3); 2,79-2,92(m, 2H, CH2); 4,27(t, J=4,6 Hz, 1H, CH); 6,95-
7,03(m, 3H, Ph-2-H, Ph-4-H, Ph-6-H); 7,14(t, J=7,4 Hz, 1H, Ph-5-H); 7,89(s,
1H, N1H); 10, 41(s, 1H, N3H);
9a 3246 1706 1755 2,24(s, 3H, CH3); 2,85-2,86(d, J=4,9 Hz, 2H, CH2); 4,25-4,29(m, 1H, CH); 
7,05(s, 4H, Ph-2-H, Ph-3-H, Ph-5-H, Ph-6-H); 7,86(s, 1H, N1H); 10, 36(s, 1H, 
N3H);
10a 3221 1730 1779 2,20 (s, 3H,CH3); 2,22 (s, 3H,CH3);2,76-2,83 (dd, 14,4 Hz 1H, H -C-H); 2,90-
2,97 (dd, J=14,4 Hz) 1H, H -C-H); 4,23-4,37 (m, 1H, CH); 6,87-6,93 (m, 2H, 
Ph-4-H, Ph-5-H); 7,00 (d, J=7,7 Hz, 1H, Ph-2-H); 7,86(s, 1H, N1H); 10, 45 (s, 
1H, N3H);
Figure 3. The image shows chiral TLC confirmation of the presence
of D-amino acids.
Analysis by TLC and Chiral TLC
The reactions were monitored by thin-layer chro-
matography using commercially available TLC alu-
minium sheets (silica gel 60 F254 Merck) using A: chlo-
roform/ethyl acetate (1:1, v/v), B: butanol/acetic
acid/water (4:1:1, v/v/v) eluents and visualized by UV
light (254 nm). The enantiomeric purities of D-amino
acids were determined using chiral thin layer chro-
matography. The samples were applied to ChiralplateÆ
Macherey-Nagel, 0.25 mm silica gel, amino acids were
eluted with C: methanol/water/acetonitrile (50:50:200,
v/v/v). Spots were visualized after spraying with 0,3%
ninhydrin and heating at 100OC for 3 ñ 5 min.
Synthesis of racemic phenyl ring-substituted 5-ben-
zylhydantoins
5-Arylidenehydantoins (1-6) were synthesized
according to Knoevenagel procedure. A mixture of 0.05
mol (5.05 g) of hydantoin, 0,05 mol of appropriate ben-
zaldehyde, 0.2 mol (16.7 g) of anhydrous sodium acetate
and 100 mL of 99,5% acetic acid was stirred and refluxed
for 5 h. The mixture was allowed to stand overnight at
ambient temperature. The precipitated crystalline material
was filtered off, washed with water and after drying
recrystallized from acetic acid. The reaction was moni-
tored by TLC with A: chloroform/ethyl acetate (1:1, v/v).
5-Arylidenehydantoins (7-10) were synthesized by
condensation of 0.01 mol (1.01 g) of hydantoin and 0.01
mol of appropriate benzaldehyde which was carried out
under microwave irradiation in the presence of 0.01 mol
(0.77 g) of ammonia acetate at 450 W of power for 1
min, and was continued after cooling for 0.5 min. The
crude 5-arylidenehydantoin was suspended in 30 mL of
99.5% acetic acid and refluxed for 0.5 h. The solution
was cooled and allowed to stand at 4OC overnight. The
precipitated crystalline material was filtered off and
washed with water.
5-Benzylhydantoins (1a-10a) were synthesized by
reduction of 0.005 mol of appropriate 5-arylidenehydan-
toin (1-10) with 4.5 mL of 57% hydroiodic acid in the
presence of 1 g of red phosphorus. The mixture was heat-
ed under reflux for 0.5 h. Afterward 30 mL of distilled
water was added and the precipitate was filtered off (8). 
Physicochemical properties
The obtained compounds (1-10) and (1a-10a) are
presented in Table 1. The IR and 1H NMR spectral data
of compounds (1a-10a) are presented in Table 2.
Compounds (1-10) were described previously by
Thenmozhiyal et al. (9). Compounds 7 and 7a were
obtained and described by Hosztafi et al. (8). Compound
9 was obtained by Tan et al. (10).
Biotransformation of phenyl ring-substituted 5-ben-
zylohydantoins 
0,125 mmol of 5-benzylhydantoin (1a-10a) was
dissolved in 0.5 mL DMSO and added to 15 mL of
buffer solution (H3BO3/HCl/NaOH, pH = 9). In this
mixture 0,3 g D-hydantoinase (53.1 U/g) was suspend-
ed. The incubation was kept at 40OC for 72 h. The
process was monitored by TLC with B: butanol/acetic
acid/water (4:1:1, v/v/v). Spots were visualized by UV
light (254 nm). The obtained N-carbamoyl-D-amino
acids (1b-10b) were not isolated (Figure 2).
Diazotization
The reaction mixture was acidified with 3.5 M HCl
to pH = 2-3. N-carbamoyl-D-amino acids (1b-10b)
were converted into the corresponding D-amino acids
(1c-10c) by means of diazotization ñ 140 µL of 3.5 M
NaNO2 solution was added and stored in 0OC for 6 h. 
Identification
The enantiomeric purities of D-amino acids were
determined using the chiral thin layer chromatography in
the presence of commercial D,L-4-fluorophenylalanine
(Nutritional Biochem. Corp.) and D,L-p-chlorophenylala-
nine (Sigma). The samples were applied to ChiralplateÆ
Macherey-Nagel, 0.25 mm silica gel and were eluted with
C: methanol/water/acetonitrile (50:50:200, v/v/v). Amino
acids were detected after spraying with 0.3% ninhydrin
and heating at 100OC for 3-5 min (Figure 3).
CONCLUSIONS
Using hydantoinase method enantiomerically pure
D-phenylalanine derivatives (1c-10c) were obtained.
Chiral TLC confirmed the presence of D-enantiomer in
the reaction mixture in high optical yield (Figure 3).
Obtained D-amino acids were not recovered from the
reaction mixture thus the reaction efficiency of hydan-
toinase method was not examined. The presence of lit-
tle amounts of unreacted 5-benzylhydantoins (1a-10a)
and N-carbamoyl-D-amino acids (1b-10b) in reaction
mixture were observed by TLC. However, all tested
phenyl ring-substituted 5-benzylohydantoins (1a-10a)
were tolerated as substrates by immobilized, cloned and
expressed in Escherichia coli D-hydantoinase (Fluka).
Condensation of compounds (7-10) was carried out
under microwave irradiation. Reactions were performed
using domestic microwave oven and gave several advan-
tages: easy work-up after the reaction, reduction of the
by-products formed in usual thermal degradation and
short reaction time compared to conventional heating. 
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